Journal
JOURNAL OF DIABETES & METABOLISM
Volume 3, Issue 5, Pages -Publisher
OMICS INT PVT LTD
DOI: 10.4172/2155-6156.1000198
Keywords
-
Categories
Funding
- NIH - National Institute of Diabetes and Digestive and Kidney Diseases [R01DK082766]
- National Genome Research Institute, USA [NOT-HG-11-009]
Ask authors/readers for more resources
The global epidemic of type 2 diabetes mellitus (T2D) is one of the most challenging problems of the 21st century and the fifth leading cause of death worldwide. Substantial evidence suggests that T2D is a multifactorial disease with a strong genetic component. Recent genome-wide association studies (GWAS) have successfully identified and replicated nearly 75 susceptibility loci associated with T2D and related metabolic traits, mostly in Europeans, and some in African, and South Asian populations. The GWAS serve as a starting point for future genetic and functional studies since the mechanisms of action by which these associated loci influence disease is still unclear and it is difficult to predict potential implication of these findings in clinical settings. Despite extensive replication, no study has unequivocally demonstrated their clinical role in the disease management beyond progression to T2D from impaired glucose tolerance. However, these studies are revealing new molecular pathways underlying diabetes etiology, gene-environment interactions, epigenetic modifications, and gene function. This review highlights evolving progress made in the rapidly moving field of T2D genetics that is starting to unravel the pathophysiology of a complex phenotype and has potential to show clinical relevance in the near future.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available